Literature DB >> 614856

Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.

S Kotani, F Kinoshita, I Morisaki, T Shimono, T Okunaga, H Takada, M Tsujimoto, Y Watanabe, K Kato, T Shiba, S Kusumoto, S Okada.   

Abstract

Addition of a lauroyl, stearoyl or docosanoyl group to the primary hydroxy group at the C-6 position of N-acetylmuramyl-L-alanyl-D-isoglutamine gave lipophilic derivatives that had definite adjuvancies in induction of delayed-type hypersensitivity and enhancement of antibody production against a test protein antigen, ovalbumin, when administered to guinea pigs as liposomes, that is without mineral oil. When administered as mineral oil-in-water emulsion, including Ribitype emulsions, rather than as water-in-mineral oil emulsions, N-acetylmuramyl-L-alanyl-D-isoglutamine and its 6-O-acyl derivatives showed only weak immunoadjuvancies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 614856

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  15 in total

1.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue.

Authors:  T W Chan; A Becker
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

2.  Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.

Authors:  G M Bahr; D S Tello; L A Chedid
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

Review 3.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

4.  Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; Y Tanio; M Kiso; A Hasegawa; Y Yamamura
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  Structure specificity of some immunoadjuvant synthetic glycopeptides.

Authors:  K Masek; M Zaoral; J Jezek; V Krchnák
Journal:  Experientia       Date:  1979-10-15

7.  Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.

Authors:  M Tsujimoto; S Kotani; F Kinoshita; S Kanoh; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

8.  Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens.

Authors:  K Yamamoto; M Kakinuma; K Kato; H Okuyama; I Azuma
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

9.  Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens.

Authors:  A J Schroit; M E Key
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

10.  Chemical and biological properties of a peptidoglycan isolated from Treponema pallidum kazan.

Authors:  T Umemoto; T Ota; H Sagawa; K Kato; H Takada; M Tsujimoto; A Kawasaki; T Ogawa; K Harada; S Kotani
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.